-
Improving the Transferability of Global RCT Data to Inform Cost-Effectiveness Models in Japan: A Structured Framework for C2H Submissions
Sep 9, 2025, 16:22 PM -
Factors Impacting GKV Rebates for Orphan Drugs (OD) in Germany: A Decision Analysis Using the CRA RADAR Database
Sep 9, 2025, 16:22 PM -
Real-World Effectiveness of Systemic Therapies in Adults with KRAS(G12C) Metastatic Colorectal Cancer in Europe: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Regulatory Approval and Economic Evaluation of Tumor-Agnostic Therapies: A Comparative Study of Larotrectinib and Entrectinib
Sep 9, 2025, 16:22 PM -
Exploratory Assessment of the Societal Impact of Changing Informal Care Hours in the Netherlands
Sep 9, 2025, 16:22 PM -
Exploring Meaningful Change in Digital Health Technologies via Qualitative Interviews
Sep 9, 2025, 16:22 PM -
Societal and Economic Impact of Immunotherapy for NSCLC Treatment in Bulgaria
Sep 9, 2025, 16:22 PM -
Trends and Scope of Japan’s Across-the-Board Pharmaceutical Price Revisions in FY2021-25
Sep 9, 2025, 16:22 PM -
Constructing a Dynamic Budget Impact Model: An AI Pretraining Approach for a New Parkinson's Disease Drug
Sep 9, 2025, 16:22 PM -
Pharmacoeconomic and Healthcare Aspects of the TDM-Guided Decisions on Biological Treatment of Inflammatory Diseases: Systematic Review of International Evidence
Sep 9, 2025, 16:22 PM -
Estimation of HER2-Negative Metastatic Breast Cancer Population Eligible for Innovative Treatments in France
Sep 9, 2025, 16:22 PM -
Drivers of Inpatient Costs in Oncology Patients Undergoing Major Abdominal Surgery: Evidence from a Middle-Income Country
Sep 9, 2025, 16:22 PM -
The Interim Acceptance and Ultraorphan Pathways in Scotland: An Update
Sep 9, 2025, 16:22 PM -
How Publication Bias May Overestimate the Risk of Serious Adverse Events Associated With Bisphosphonate Use
Sep 9, 2025, 16:22 PM -
Disability Resource Utilization and Caregiver Support Among a Real-World Sample of Patients With Transthyretin Amyloidosis With Polyneuropathy
Sep 9, 2025, 16:22 PM -
Recognizing the Full Value of Novel Antibiotics: Identifying Value Elements in the Context of Antimicrobial Resistance
Sep 9, 2025, 16:22 PM -
Adherence to Anti-VEGF Treatment of Patients With Age-Related Macular Degeneration of Exudative Type (nAMD) and Diabetic Macular Edema (DME) in Greece: Evidence From an Expert Panel
Sep 9, 2025, 16:22 PM -
Potential Implications of EU Joint Clinical Assessment (JCA) for the UK Affiliate of a Global Pharmaceutical Company
Sep 9, 2025, 16:22 PM -
Comorbidities and Comedication Among Individuals in Treatment for ADHD: A Danish Nationwide Study
Sep 9, 2025, 16:22 PM -
Where Is AI in Evidence Synthesis for NICE HTA Submissions?
Sep 9, 2025, 16:22 PM
